Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BCM-95 Curcumin and BosPure Boswellia Compared to Arthritis Drug - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

BCM-95 Curcumin and BosPure Boswellia Compared to Arthritis Drug

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

The Osteoarthritis Research Society International (OARSI) has accepted for presentation and poster publication a study comparing BCM-95 curcumin combined with BosPure boswellia (from EuroPharma, Green Bay, WI) and the prescription drug celecoxib, which is sold under the brand name Celebrex in the U.S. The study is scheduled for presentation at the OARSI meeting in September.

The study compared a 500 mg blend of BCM-95 curcumin and BosPure boswellia administered twice daily, compared to 100 mg of celecoxib twice daily. Thirty volunteers participated in the 12-week study. Not only were pain and stiffness assessed, but liver, kidney and blood tests were done at each visit to assess safety and tolerability.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters